Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $101.9600 (-1.15%) ($101.4300 - $103.9700) on Thu. Mar. 2, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.99% (three month average) | RSI | 37 | Latest Price | $101.9600(-1.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.2% a day on average for past five trading days. | Weekly Trend | LGND declines -1.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(53%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -0.995% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.995% (StdDev 1.99%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
Resistance Level | $105.3 | 5 Day Moving Average | $103.5(-1.49%) | 10 Day Moving Average | $103.95(-1.91%) | 20 Day Moving Average | $105.3(-3.17%) | To recent high | -6.8% | To recent low | 1.6% | Market Cap | $1.639b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |